The FDA On Personal Importation Of Drugs

• The best FDA cGMP online training programs and courses by SkillsPlus International Inc.
• Board-approved California Designated Representative online training programs for wholesaler, 3PL, and reverse distributor license applicants

You might be interested in how the FDA thinks about the personal importation of drugs.

Here are two links that I find very useful:

• Personal Importation - FDA.gov
• Importation of Prescription Drugs Final Rule Questions and Answers; Small Entity Compliance Guide - Guidance Document - FDA.gov

FDA calls states’ bluffs on drug importation - STAT News

• California Designated Representative Training - for wholesalers, 3PL. $525 per student. Board approved. Earns a training affidavit suitable for your license application.
• People also buy these California Des Rep training classes for:
       Wholesalers | 3PL | Reverse Distributors

According to the article:

"For decades, critics of the U.S. drug pricing system have advocated importing drugs from Canada as a convenient shortcut to lower prices. The Food and Drug Administration’s recent release of a proposed regulation to create a process for approving state-sponsored importation plans is one step closer to that goal. A closer look shows that it’s actually a false step."

Read the full source article:  FDA calls states’ bluffs on drug importation - STAT News

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

-------------------

California Designated Representative Training - for wholesalers, 3PL. $525 per student. Board approved. Earns a training affidavit suitable for your license application.

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
Designated Rep Certification Class
CA Designated Representative Training Program
California Designated Representative Training Program
California HMDR Exemptee Training
Exemptee Certification Class
FL CDR Exam Prep
SkillsPlus Intl Inc. - The Leader in Compliance Training
The Health, Drug, Prescription, and GMP Supersite Gift Store 

FDA Prohibits Drug Importation from Ranbaxy’s Plant in Mohali, India

Press Announcements > FDA prohibits manufacture of FDA-regulated drugs from Ranbaxy’s Mohali, India, plant and issues import alert:

"The U.S. Food and Drug Administration today issued an import alert under which U.S. officials may detain at the U.S. border drug products manufactured at Ranbaxy Laboratories, Ltd.’s facility in Mohali, India. The firm will remain on the import alert until the company complies with U.S. drug manufacturing requirements, known as current good manufacturing practices (CGMP)."

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog

The Exemptee Institute
The Designated Representative Institute

The Health, Drug, Prescription, and GMP Supersite Gift Store